Videbech Poul
Center for Psykiatrisk Forskning, Aarhus Universitetshospital, Risskov, Skovagervej 2, 8240 Risskov, Denmark.
Ugeskr Laeger. 2012 Feb 6;174(6):348-51.
A systematic review of the literature on modafinil as adjunctive treatment to antidepressants in patients with major depression and residual symptoms of fatigue and drowsiness is presented. Several open-labelled studies have shown good results on treatment with modafinil. However, only a few randomised controlled clinical trials exist. These have methodological weaknesses and their results are contradictory. If modafinil is used in highly selected patients with severe fatigue its potential interactions with antidepressants must be borne in mind. Furthermore, discontinuation of the drug should be tried after a couple of months, as one study suggests that the effect wears off. In addition, the drug is rather expensive.
本文对莫达非尼作为抗抑郁药辅助治疗重度抑郁症伴疲劳和嗜睡残留症状患者的文献进行了系统综述。多项开放性研究显示莫达非尼治疗效果良好。然而,仅有少数随机对照临床试验。这些试验存在方法学缺陷,结果相互矛盾。如果在经过严格筛选的重度疲劳患者中使用莫达非尼,必须牢记其与抗抑郁药的潜在相互作用。此外,正如一项研究所表明的,该药效果会逐渐消失,因此几个月后应尝试停药。另外,该药相当昂贵。